

Advancements in cell & gene therapy manufacturing (Part II)
May 17, 2024
Delara Motlagh, Becky Butler Cap, and Kevin Kyle discuss cell collection, scaling projects from lab to clinic, and Germfree's decentralized manufacturing mission. Topics include locking in process decisions early, Catalent's new production site, and Germfree's recent asset acquisition from Orgenesis.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 2min
Innovations and Challenges in Cell and Gene Therapy Manufacturing
01:42 • 17min
Streamlining Cell and Gene Therapy Development with Advanced Platforms
18:15 • 5min
Exploring Decentralized Manufacturing in Cell and Gene Therapy
23:34 • 6min
Importance of Retaining Samples in Cell & Gene Therapy Manufacturing Process
29:15 • 2min